Treace Medical Concepts I... (TMCI)
undefined
undefined%
At close: undefined
7.90
-0.25%
After-hours Jan 03, 2025, 04:00 PM EST

Company Description

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.

It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement.

The company also provides Lapiplasty Mini-Incision precision system.

In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion.

Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Treace Medical Concepts Inc.
Treace Medical Concepts Inc. logo
Country United States
IPO Date Apr 23, 2021
Industry Medical - Devices
Sector Healthcare
Employees 516
CEO John T. Treace

Contact Details

Address:
203 Fort Wade Road
Ponte Vedra, Florida
United States
Website https://www.treace.com

Stock Details

Ticker Symbol TMCI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001630627
CUSIP Number 89455T109
ISIN Number US89455T1097
Employer ID 47-1052611
SIC Code 3841

Key Executives

Name Position
John T. Treace Chief Executive Officer, Founder & Director
Mark L. Hair CPA Chief Financial Officer
Taylor Erickson Chief Information Officer
Aaron J. Berutti Senior Vice President of Sales
Daniel E. Owens Chief Human Resources Officer
Dr. Sean F. Scanlan Ph.D. Chief Innovation Officer
Nathan Minnich Senior Vice President of Marketing
Scot M. Elder J.D. Chief Legal & Compliance Officer and Corporate Secretary
Shana Zink Senior Vice President of Clinical Affairs & Reimbursement
Terry W. Lubben Chief Operations & Supply Chain Officer

Latest SEC Filings

Date Type Title
Dec 05, 2024 4 Filing
Dec 05, 2024 3 Filing
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 13, 2024 4 Filing
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 07, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 05, 2024 10-Q Quarterly Report
Nov 05, 2024 8-K Current Report
Nov 04, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...